Memoton-Life

Galantamine, the active ingredient in Memoton-Life, is an acetylcholinesterase inhibitor presented as an oral tablet for oral use. It is indicated for the treatment of mild to moderate Alzheimer’s disease in adult patients, helping to improve cognitive function. GNH USA supplies Memoton-Life as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution aligned to EU regulatory standards. The company ensures product quality, traceability and compliance with Good Distribution Practice throughout the supply chain globally.

Galantamine is employed in the management of Alzheimer’s disease, a progressive neurodegenerative disorder that impairs memory, thinking and behavior.

Mild to moderate Alzheimer’s disease: improves cognitive function, memory recall and the ability to perform daily activities. Early‑stage Alzheimer’s disease: may delay the progression of memory loss and support attention span. Alzheimer’s disease‑associated dementia: helps maintain executive function and reduces caregiver‑reported functional decline.

The most frequently reported adverse reactions with galantamine are:

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional episodes. - Diarrhea: loose stools. - Dizziness: light‑headed sensation.

Less common but potentially serious reactions include: Serious or Rare Side Effects: - Severe liver injury: jaundice, elevated liver enzymes. - Cardiac arrhythmias: irregular heartbeat. - Seizures: convulsive episodes.

When prescribing galantamine, clinicians should consider several safety factors.

Renal impairment: adjust therapy and monitor renal function. Hepatic impairment: use with caution; monitor liver enzymes. Cardiovascular disease: assess for bradycardia or conduction abnormalities. Respiratory conditions: avoid in uncontrolled asthma or COPD. Concomitant anticholinergics: may reduce therapeutic effect. Store at ambient temperature: keep in original container, protect from moisture and heat.

Galantamine can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticholinergic agents: may reduce galantamine efficacy. - Beta‑blockers: can increase risk of bradycardia. - CYP2D6 inhibitors: raise galantamine plasma concentrations.

Moderate Interactions (Monitor Closely): - Other cholinesterase inhibitors: additive cholinergic effects. - Tricyclic antidepressants: may heighten side‑effect profile. - NSAIDs: can increase gastrointestinal discomfort.